The project broke ground June 25 and is scheduled for completion in 2012.
The 630,000-square-foot project (57,000 sq m) (above centered rendering) features an emergency department, diagnostic and ambulatory programs, education and research centers, integrated with an outpatient clinic on a 60-acre greenfield site.
When completed, the campus will allow Nemours to provide access to a full-line of specialty services and improve pediatric care to the region through coordinated patient-centered medical services, biomedical research, medical and allied health training, educational programs as well as pediatric prevention services and child advocacy programs.
Additionally, the facility will incorporate high performance, environmentally friendly and sustainable design concepts to achieve LEED® certification from the United States Green Building Council.
Skanska USA Building is a leading national and local provider of construction, pre-construction consulting, general contracting and design-build services.
The company also provides validation services to clients in the pharmaceutical industry. Clients represent a broad range of U.S. industries including science and technology, healthcare, education, high-tech, aviation, transportation and sports and entertainment.
The business unit is headquartered in Parsippany, New Jersey and has approximately 3,500 employees. Sales in 2008 amounted to about SEK 30.3 billion.
Skanska is one of the world’s leading project development and construction groups with expertise in construction, development of commercial and residential projects and public-private partnerships.
The Group currently has 55,000 employees in selected home markets in Europe, in the US and Latin America. Headquartered in Stockholm, Sweden and listed on the Stockholm Stock Exchange, Skanska's sales in 2008 totaled SEK 144 billion.
Contacts:
Skanska USA Building,Tom Crane, Senior Vice President, Communications, tel +1 973 753 3450
Skanska AB, Peter Gimbe, Press Officer, tel +46 10 448 88 38 or
Direct line for media:tel +46 10 448 88 99
No comments:
Post a Comment